STOCK TITAN

[25-NSE] Amedisys Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
25-NSE

Amedisys Inc (AMED) submitted a Form 25 notification indicating the removal or withdrawal of a class of its securities from listing and/or registration on the Nasdaq Stock Market LLC. The filing identifies the issuer name, Nasdaq as the exchange and provides the company's Baton Rouge address and phone number. The form references rule provisions under 17 CFR 240.12d2-2 and states the Exchange and/or the issuer have complied with applicable procedures for striking the class from listing or voluntary withdrawal. The copy provided does not include which specific checkbox was marked, the class of securities affected, or an authorized signature and date.

Amedisys Inc (AMED) ha presentato un modulo Form 25 notificando la rimozione o il ritiro di una classe di titoli dalla quotazione e/o registrazione presso il Nasdaq Stock Market LLC. La comunicazione indica il nome dell'emittente, il Nasdaq come borsa e fornisce l'indirizzo e il numero di telefono della società a Baton Rouge. Il modulo fa riferimento alle disposizioni del regolamento 17 CFR 240.12d2-2 e dichiara che la Borsa e/o l'emittente hanno rispettato le procedure applicabili per la cancellazione dalla quotazione o il ritiro volontario. La copia disponibile non specifica quale casella sia stata selezionata, quale classe di titoli sia interessata né riporta una firma e una data autorizzata.

Amedisys Inc (AMED) presentó un Formulario 25 notificando la eliminación o el retiro de una clase de sus valores de la cotización y/o registro en el Nasdaq Stock Market LLC. La presentación identifica al emisor, al Nasdaq como la bolsa y proporciona la dirección y el teléfono de la empresa en Baton Rouge. El formulario hace referencia a las disposiciones normativas 17 CFR 240.12d2-2 y afirma que la Bolsa y/o el emisor han cumplido los procedimientos aplicables para la exclusión de cotización o la retirada voluntaria. La copia disponible no indica qué casilla se marcó, qué clase de valores se vio afectada ni incluye una firma autorizada y la fecha.

Amedisys Inc (AMED)는 Nasdaq Stock Market LLC에서 자사 증권의 특정 등급을 상장 및/또는 등록 취소·철회한다는 사실을 알리는 Form 25를 제출했습니다. 해당 제출서에는 발행인명, 거래소로서의 Nasdaq, 그리고 회사의 배턴루지 주소와 전화번호가 기재되어 있습니다. 서류는 17 CFR 240.12d2-2 규정 조항을 참조하며, 거래소 및/또는 발행인이 상장 말소 또는 자발적 철회에 관한 적용 절차를 준수했음을 명시합니다. 제공된 사본에는 어떤 체크박스가 선택되었는지, 어떤 증권 등급이 영향을 받았는지, 또는 승인된 서명과 날짜가 포함되어 있지 않습니다.

Amedisys Inc (AMED) a soumis un formulaire 25 signalant la radiation ou le retrait d'une catégorie de ses titres de la cotation et/ou de l'enregistrement sur le Nasdaq Stock Market LLC. le dépôt identifie l'émetteur, le Nasdaq comme marché et fournit l'adresse et le numéro de téléphone de la société à Baton Rouge. Le formulaire renvoie aux dispositions réglementaires 17 CFR 240.12d2-2 et indique que la Bourse et/ou l'émetteur ont respecté les procédures applicables pour la radiation de la cotation ou le retrait volontaire. La copie fournie n'indique pas quelle case a été cochée, quelle catégorie de titres est concernée, ni ne comporte de signature autorisée ni de date.

Amedisys Inc (AMED) hat ein Formular 25 eingereicht, mit dem die Entfernung oder der Rückzug einer Klasse von Wertpapieren von der Notierung und/oder Registrierung an der Nasdaq Stock Market LLC angezeigt wird. Die Einreichung nennt den Emittenten, Nasdaq als Börse und gibt die Adresse sowie Telefonnummer des Unternehmens in Baton Rouge an. Das Formular verweist auf Regelbestimmungen nach 17 CFR 240.12d2-2 und erklärt, dass die Börse und/oder der Emittent die anwendbaren Verfahren zur Streichung von der Notierung bzw. zum freiwilligen Rückzug eingehalten haben. Die vorliegende Kopie nennt nicht, welches Kontrollkästchen angekreuzt wurde, welche Wertpapierklasse betroffen ist, noch enthält sie eine autorisierte Unterschrift und ein Datum.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: The filing formally notifies Nasdaq removal/withdrawal of AMED securities but lacks execution details required for full shareholder clarity.

The Form 25 in the record indicates a formal step to remove or withdraw Amedisys securities from Nasdaq listing under the cited 17 CFR provisions. From a governance perspective, this is a significant corporate action because delisting or withdrawal affects shareholder liquidity and regulatory status. The document as provided omits which rule subsection was checked, the specific class of securities, and the signature/date block is blank, limiting confirmation of completion and timing. These omissions hinder stakeholders' ability to verify procedural compliance and the effective date of removal.

TL;DR: Form 25 notification signals a material change in trading/registration status for AMED, but the filing here is incomplete.

As a securities disclosure, this Form 25 communicates an intention or action to strike Amedisys shares from Nasdaq listing/registration under 17 CFR 240.12d2-2. That action is material to investors because it can affect share liquidity and listing compliance. However, the provided content lacks the marked rule provision, the class of security affected, and the authorized signature/date, so the record does not confirm the effective removal date or finality of the action. Further documentation would be required to assess timing and market impact.

Amedisys Inc (AMED) ha presentato un modulo Form 25 notificando la rimozione o il ritiro di una classe di titoli dalla quotazione e/o registrazione presso il Nasdaq Stock Market LLC. La comunicazione indica il nome dell'emittente, il Nasdaq come borsa e fornisce l'indirizzo e il numero di telefono della società a Baton Rouge. Il modulo fa riferimento alle disposizioni del regolamento 17 CFR 240.12d2-2 e dichiara che la Borsa e/o l'emittente hanno rispettato le procedure applicabili per la cancellazione dalla quotazione o il ritiro volontario. La copia disponibile non specifica quale casella sia stata selezionata, quale classe di titoli sia interessata né riporta una firma e una data autorizzata.

Amedisys Inc (AMED) presentó un Formulario 25 notificando la eliminación o el retiro de una clase de sus valores de la cotización y/o registro en el Nasdaq Stock Market LLC. La presentación identifica al emisor, al Nasdaq como la bolsa y proporciona la dirección y el teléfono de la empresa en Baton Rouge. El formulario hace referencia a las disposiciones normativas 17 CFR 240.12d2-2 y afirma que la Bolsa y/o el emisor han cumplido los procedimientos aplicables para la exclusión de cotización o la retirada voluntaria. La copia disponible no indica qué casilla se marcó, qué clase de valores se vio afectada ni incluye una firma autorizada y la fecha.

Amedisys Inc (AMED)는 Nasdaq Stock Market LLC에서 자사 증권의 특정 등급을 상장 및/또는 등록 취소·철회한다는 사실을 알리는 Form 25를 제출했습니다. 해당 제출서에는 발행인명, 거래소로서의 Nasdaq, 그리고 회사의 배턴루지 주소와 전화번호가 기재되어 있습니다. 서류는 17 CFR 240.12d2-2 규정 조항을 참조하며, 거래소 및/또는 발행인이 상장 말소 또는 자발적 철회에 관한 적용 절차를 준수했음을 명시합니다. 제공된 사본에는 어떤 체크박스가 선택되었는지, 어떤 증권 등급이 영향을 받았는지, 또는 승인된 서명과 날짜가 포함되어 있지 않습니다.

Amedisys Inc (AMED) a soumis un formulaire 25 signalant la radiation ou le retrait d'une catégorie de ses titres de la cotation et/ou de l'enregistrement sur le Nasdaq Stock Market LLC. le dépôt identifie l'émetteur, le Nasdaq comme marché et fournit l'adresse et le numéro de téléphone de la société à Baton Rouge. Le formulaire renvoie aux dispositions réglementaires 17 CFR 240.12d2-2 et indique que la Bourse et/ou l'émetteur ont respecté les procédures applicables pour la radiation de la cotation ou le retrait volontaire. La copie fournie n'indique pas quelle case a été cochée, quelle catégorie de titres est concernée, ni ne comporte de signature autorisée ni de date.

Amedisys Inc (AMED) hat ein Formular 25 eingereicht, mit dem die Entfernung oder der Rückzug einer Klasse von Wertpapieren von der Notierung und/oder Registrierung an der Nasdaq Stock Market LLC angezeigt wird. Die Einreichung nennt den Emittenten, Nasdaq als Börse und gibt die Adresse sowie Telefonnummer des Unternehmens in Baton Rouge an. Das Formular verweist auf Regelbestimmungen nach 17 CFR 240.12d2-2 und erklärt, dass die Börse und/oder der Emittent die anwendbaren Verfahren zur Streichung von der Notierung bzw. zum freiwilligen Rückzug eingehalten haben. Die vorliegende Kopie nennt nicht, welches Kontrollkästchen angekreuzt wurde, welche Wertpapierklasse betroffen ist, noch enthält sie eine autorisierte Unterschrift und ein Datum.

UNITED STATES
OMB APPROVAL
OMB Number: 3235-0080
Expires: March 31, 2018
Estimated average burden
hours per response: 1.7
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-24260
Issuer: AMEDISYS INC
Exchange: Nasdaq Stock Market LLC
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
Address: 3854 American Way, Suite A
Baton Rouge LOUISIANA 70816
Telephone number: 1 225 292-2031
(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
Common Stock
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
17 CFR 240.12d2-2(a)(1)
17 CFR 240.12d2-2(a)(2)
17 CFR 240.12d2-2(a)(3)
17 CFR 240.12d2-2(a)(4)
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
2025-08-14 By Tara Petta AVP
Date Name Title
1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Amedisys Inc

NASDAQ:AMED

AMED Rankings

AMED Latest News

AMED Latest SEC Filings

AMED Stock Data

3.32B
32.24M
1.95%
96.37%
9.73%
Medical Care Facilities
Services-home Health Care Services
Link
United States
BATON ROUGE